Approval · Notice of Compliance 28082 · 2022
ESAMUZE: Notice of Compliance 28082
Issued May 4, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28082
- Date
- May 4, 2022
- Company
- Dr Reddys Laboratories Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESAMUZE | 02527073 | Approved |
Medicinal ingredients
- BENDAMUSTINE HYDROCHLORIDE 45 MG per ML